Medications Flashcards

1
Q

Acetaminophen Trade Names

A

Tylonol, Tempra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acetaminophen AHS Protocols - Adult

A

-Pain management
-Antipyretic therapy; greater than 38° C
-Headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acetaminophen AHS Protocols - Pediatric

A

-Pain management
-Antipyretic therapy; greater than 38° C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Acetaminophen Classification

A

-Non-Opioid analgesic
-Antipyretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acetaminophen Mechanism Of Action

A

-Inhibits the synthesis of prostaglandins that may serve as mediators of pain and fever; does not have any significant anti-inflammatory properties.
-Inhibits prostaglandin synthesis in the central nervous system by blocking pain impulse generation.
-Acts on the hypothalamic heat regulating canter to produce peripheral vasodilation resulting in increased blood flow through the skin, sweating, and heat loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acetaminophen Indications

A

-Mild pain management
-Reduction of fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acetaminophen Contraindications

A

-Hypersensitivity to alcohol, aspartame, saccharin, sugar, FDC yellow dye #5 (food colouring)
-Active liver disease / hepatic impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acetaminophen Dosage - Adult

A

975mg PO, No repeat dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Acetaminophen Dosage - Pediatric

A

15mg/kg PO, max dose of 975mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Acetaminophen Side Effects

A

-Renal failure due to high doses / chronic use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acetaminophen Pharmacokinetics

A

Onset - 15-30 minutes
Duration - 4-6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acetaminophen EMS Considerations

A

-Do not administer if the patient has taken the maximum dose of 975mg witching 4 hours.
-If the patient has received less than 975mg witching 4 hours, administer remaining medication to obtain max dose of 975mg.
-Ensure to document patient’s temperature prior to administration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acetylsalicylic Acid Trade Names

A

-ASA
-Aspirin
-Bufferin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Acetylsalicylic Acid AHS Protocols

A

Acute Coronary Syndrome (suspected)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acetylsalicylic Acid Classifications

A

-Antiplatelet
-Analgesic
-Antipyretic
-Non-steroidal anti-inflammatory drug (NSAID)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acetylsalicylic Acid Mechanism Of Action

A

-Blocks the formation of thromboxane A2, which is responsible for platelets aggregating and arteries constricting.
-Producing analgesia and has anti-inflammatory, and antipyretic effects by inhibiting the production of prostaglandins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Acetylsalicylic Acid Indications

A

-Antiplatelet therapy in Acute Coronary Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Acetylsalicylic Acid Contraindications

A

-Hypersensitivity to salicylates / NSAIDs
-Unconscious / unable to follow commands
-Active ulcer disease / GI hemorrhage
-Bleeding disorders
-Pregnancy (especially 3rd trimester)
-Children under 15 years of age
-ASA induced asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Acetylsalicylic Acid Dosage

A

160mg - 162mg PO chewed, total max in 24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Acetylsalicylic Acid Side Effects

A

-GI irritation
-Nausea / vomiting
-Tinnitus
-Increased risk of bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Acetylsalicylic Acid Pharmacokinetics

A

Onset - 1-2 hours
Duration - 4-5 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Acetylsalicylic Acid EMS Considerations

A

-Withhold EMS dose if it is confirmed that patient took ASA properly previous to arrival of EMS.
-ASA must still be administered even if patient has taken their daily dose or are on blood thinners.
-Patients taking anticoagulant therapy, ASA may potentiate the effect.
-Diabetics taking ASA and oral hypoglycemic or insulin should be closely monitored for hypoglycemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Dextrose in Water Trade Names

A

-D10W
-D25W
-D50W

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Dextrose in Water AHS Protocol - Adult

A

-Head injury
-Hypoglycemia
-Stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Dextrose in Water AHS Protocols - Pediatric

A

-Hypoglycemia (D10W; D25W)
-Head injury (D25W)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Dextrose in Water Classification

A

-Caloric agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Dextrose in Water Mechanism Of Action

A

-Increases blood sugar levels to normal cases on hypoglycemia.
-Hypertonic solution producing a transient movement of water from interstitial spaces into the venous system (osmotic diuretic).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Dextrose in Water Indications

A

-Severe, symptomatic hypoglycemia from any cause.
-Head injury with symptomatic hypoglycemia (half dose).
-Stroke with symptomatic hypoglycemia (half dose).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Dextrose in Water Contraindications

A

-Allergy to corn or corn products
-Hyperglycemia
-Hypersensitivity to dextrose solution
-Intracranial hemorrhage (half dose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Dextrose in Water Dosage - Adult; Symptomatic Hypoglycemia

A

25g D50W SIVP / IO q 5 min prn, titrate to BGL >/= 4.0mmol/L or patient improvement
Max 50g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Dextrose in Water Dosage - Adult; Suspected Stroke

A

12.5g D50W SIVP / IO q 5 min prn, titrate BGL = 3.0mmol/L or patient improvement
Max 50g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Dextrose in Water Dosage - Adult; Suspected Head Injury

A

12.5g D50W SIVP / IO q 5 min prn, titrate BGL = 4.0mmol/L or patient improvement
Max 50g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Dextrose in Water Dosage - Pediatric; Less than 10kg

A

0.5g/kg D10W SIVP / IO q 5 min prn, titrate to BGL 4.0mmol/L or patient improvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Dextrose in Water Dosage - Pediatric; More than 10kg / less than 40kg

A

0.5g/kg D25W SIVP / IO to a single max dose of 12.5g q 5 min, titrate BGL 4.0mmol/L or patient improvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Dextrose in Water Dosage - Pediatric; More than / Equal to 40kg

A

12.5g D50W SIVP / IO q 5 min prn, single max dose, titrate BGL 4.0 mmol/L or patient improvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Dextrose in Water - Create D10W

A

-Remove 40mL D50W preload, replace with 40mL of normal saline
-New concentration of 5g/50mL = 100mg/mL
((0.5g X kg) X 50mL) divided by 5g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Dextrose in Water - Create D25W

A

-Remove 25mL from the D50W preload, replace with 25mL of normal saline.
-New concentration of 12.5g/50mL = 250mg/mL
((0.5g X kg) X 50mL) divided by 12.5g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Dextrose in Water Side Effects

A

-Rebound hyperglycemia
-May aggravate hypertension / CHF
-May cause neurological symptoms in an alcoholic patient
-Werkinick’s encephalopathy / Korsakoff’s syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Dextrose in Water Pharmacokinetics

A

Onset - <1 minutes
Duration - Varies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Dextrose in Water EMS Considerations

A

-Tissue necrosis if infiltration occurs, to avoid; give 1/2 the total volume and check IV patency before administering the rest.
-Utilize a large bore catheter in a large vein.
-D50W has a short duration of action, therefore follow drug administration with an oral complex carbohydrate (toast, pasta, sandwich).
-Increased intracellular glucose levels in the setting of cerebral ischemia and hypoxia result in increased intracellular acidosis due to anaerobic metabolism of glucose and subsequent neuronal death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Dimenhydrinate Trade Name

A

Gravol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Dimenhydrinate AHS Protocols

A

Nausea / vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Dimenhydrinate Classification

A

Antiemetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Dimenhydrinate Mechanism Of Action

A

-Depresses vestibular (equilibrium) function by inhibiting histamine H1 receptors
-Sedative effects due to inhibition of histamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Dimenhydrinate Indications

A

Nausea / vomiting associated with motion sickness and vertigo

46
Q

Dimenhydrinate Contraindications

A

-Hypersensitivity to Dimenhydrinate and Diphenhydramine or propylene glycol (food additive)
-Narrow angle glaucoma
-Patients who have ingested large quantities of depressants including alcohol

47
Q

Dimenhydrinate Dosage

A

50mg SIVP / IM q 4 hours
25mg SIVP / IM for patients over 65 years, no repeat dose

48
Q

Dimenhydrinate Side Effects

A

-Drowsiness
-Sedative effect

49
Q

Dimenhydrinate Pharmacokinetics

A

Onset- IV immediate; IM 20-30 minutes
Duration- 3-6 hours

50
Q

Dimenhydrinate EMS Considerations

A

-Generally administered in 10mL syringe with normal saline for IV administration
-Preferred antiemetic for nausea / vomiting associated with vertigo, motion sickness, narcotic side effect, pregnancy

51
Q

Diphenhydramine Trade Name

A

Benadryl

52
Q

Diphenhydramine AHS Protocols - Adult

A

-Allergic reaction
-Anaphylaxis

53
Q

Diphenhydramine AHS Protocols - Pediatric

A

-Allergic reaction
-Anaphylaxis

54
Q

Diphenhydramine Classification

A

Antihistamine

55
Q

Diphenhydramine Mechanism Of Action

A

-Competes with histamine for H1 receptor sites on effector cells. They thereby prevent, but do not reverse responses mediated by histamine alone.
-Does not inhibit histamine release

56
Q

Diphenhydramine Indications

A

-Allergic reactions
-Adjunct to epinephrine (used after epinephrine deployed) in the management of anaphylaxis
-Management of drug induced extrapyramidal symptoms

57
Q

Diphenhydramine Contraindications

A

-Hypersensitivity to Diphenhydramine and Dimenhydrinate
-Avoid antihistamine n nursing mothers and / or in neonates (less than 28 days) unless life threatening anaphylaxis / allergy

58
Q

Diphenhydramine Dosage - Adults

A
  • (Elixer) 50mg PO, no repeat dose
    -1mg/kg SIVP / IM / IO, 50mg, no repeat dose
59
Q

Diphenhydramine Dosage - Pediatrics

A

-(Elixer) 1mg/kg PO, 50mg max dose, no repeat dose
-1mg/kg SIVP / IM / IO, 50mg max dose, no repeat dose

60
Q

Diphenhydramine Side Effects

A

-Dry mouth / throat
-Blurred vision
-Hypotension
-Thickening of bronchial secretions
-Bronchospasm

61
Q

Diphenhydramine Pharmacokinetics

A

Onset - 15 minutes PO, 5-10 minutes IM / IV
Peak effects - 1-4 hours

62
Q

Diphenhydramine EMS Considerations

A

-Diphenhydramine is not recommended in neonates due to increased susceptibility to anticholinergic effects however should be administered judiciously in setting of anaphylaxis

63
Q

Epinephrine 1mg/mL (1:1000) Trade Name

A

Adrenaline

64
Q

Epinephrine 1mg/mL (1:1000) AHS Protocols - Adult

A

Anaphylaxis

65
Q

Epinephrine 1mg/mL (1:1000) AHS Protocols - Pediatric

A

Anaphylaxis

66
Q

Epinephrine 1mg/mL (1:1000) Classifications

A

Sympathomimetic, endogenous catecolamine

67
Q

Epinephrine 1mg/mL (1:1000) Mechanism Of Action

A

-Inhibits the release of histamine associated with allergic and anaphylactic reactions.
- Alpha 1 agonist - peripheral vasoconstriction improving coronary and cerebral perfusion.
-Beta 1 agonist - positive chronotripic, inotropic, dromotropic properties, increases automaticity in the heart.
-Beta 2 agonist - bronchodilation - adrenergic receptors in the lungs to relax bronchial smooth muscle.

68
Q

Epinephrine 1mg/mL (1:1000) Indication

A

Analphylaxis

69
Q

Epinephrine 1mg/mL (1:1000) Contraindications

A

-None in emergent situations
-Hypersensitivity to epinephrine

70
Q

Epinephrine 1mg/mL (1:1000) Dosage - Adult

A

0.3mg (1mg/mL) IM q 5 prn, max 0.9mg

71
Q

Epinephrine 1mg/mL (1:1000) Dosage - Pediatric; Less than 30kg

A

0.15mg IM q 5 min, total max 0.45mg
Vastus lateralis for injection

72
Q

Epinephrine 1mg/mL (1:1000) Dosage - Pediatric; More than / Equal to 30kg

A

0.3mg IM q 5 min, total max 0.9mg
Vastus lateralis for injection

73
Q

Epinephrine 1mg/mL (1:1000) Side Effects

A

-Palpitation
-Tremors
-Nervousness
-Dizziness
-Anxiety
-Headache
-Hypertension
-Tachycardia

74
Q

Epinephrine 1mg/mL (1:1000) Pharmacokinetics

A

Onset - 5-10 minutes (IM)
Peak effects - 20 minutes

75
Q

Epinephrine 1mg/mL (1:1000) EMS Considerations

A

-All patients receiving this medication must be cardiac monitored.
-Do not administer 1mg/mL solution by direct IV.
-Epinephrine in pregnancy can cause fetal hypoxia.
-Ensure patient is in recumbent position prior to administration of epinephrine.

76
Q

Glucagon AHS Protocols - Adult

A

Hypoglycemia

77
Q

Glucagon AHS Protocols - Pediatric

A

Hypoglycemia

78
Q

Glucagon Classification

A

Hormone

79
Q

Glucagon Mechanism Of Action

A

-Causes an increase in blood glucose by stimulating glucagen breakdown in the liver, converting glucagen to glucose.

80
Q

Glucagon Indications

A

-Confirmed hypoglycemia in which an IV cannot be established

81
Q

Glucagon Contraindications

A

-Hypersensitivity to glucagon, beef, or pork proteins
-Pheochromocytoma
-Hyperglycemia

82
Q

Glucagon Dosage - Adult

A

1mg IM q 15 prn, total max 2mg

83
Q

Glucagon Dosage - Pediatric; Less than 20kg

A

0.5mg IM q 15 min prn, total max 1mg

84
Q

Glucagon Dosage - Pediatric; More than 20kg

A

1mg IM q 15 min prn, total max

85
Q

Glucagon Side Effects

A

-Dizziness
-Headache
-Hypertension
-Tachycardia
-Rebound hyperglycemia

86
Q

Glucagon Pharmacokinetics

A

Onset - 5- 15 minutes (IM)

87
Q

Glucagon EMS Considerations

A

-Use of glucagon in patients with pheochromocytoma can cause the tumour to release catecholamines resulting in hypertensive crisis.
-D50W is the drug of choice in hypoglycemia.
-Effective only if there are sufficient stores of glycogen within the liver.
-A complex carbohydrate must be given after administration of medication to prevent relapse after hypoglycemia is corrected (toast, pasta, sandwich).

88
Q

Ibuprofen Trade Names

A

-Advil
-Motrin

89
Q

Ibuprofen AHS Protocols - Adult

A

-Pain Management
-Antipyretic therapy; greater than 38° C
-Headache

90
Q

Ibuprofen AHS Protocols - Pediatric

A

-Pain management
-Antipyretic therapy; greater than 38° C

91
Q

Ibuprofen Classifications

A

-Non-steroidal anti-inflammatory drug (NSAID)
-Non-opioid analgesic

92
Q

Ibuprofen Mechanism Of Action

A

-Inhibits prostaglandin synthesis, decreasing pain and inflammation through non-selective, reversible inhibition of cyclooxygenase enzymes, COX-1 and COX-2

93
Q

Ibuprofen Indications

A

-Treatment of mild pain associated with arthritis, pain in muscles, joints, or bones.
-Reduction of fever for adults or children over 6 months old.
-Dysmenorrhea or headaches

94
Q

Ibuprofen Contraindications

A

-Hypersensitivity to NSAIDs / salicylates
-Suspected intracranial bleeding
-Sub-arachnoid hemorrhage (indicated by sudden onset / most severe headache ever)
-Ibuprofen induced asthma
-Renal disease, except renal colic
-Diagnosis of crohns / ulcerative colitis / IBD
- Patient currently taking oral anticoagulants
-Patient undergoing chemotherapy
-Pregnancy

95
Q

Ibuprofen Dosage - Adult

A

400mg PO - No repeat dose

96
Q

Ibuprofen Dosage - Pediatric

A

10mg/kg PO - max dose 400mg

97
Q

Ibuprofen Side Effects

A

-Mild hypertension
-GI irritation
-Nausea / vomiting
-Constipation
-Tinnitus
-Increased risk of bleeding

98
Q

Ibuprofen Pharmacokinetics

A

Onset - 30 mins
Duration - 4-8 hours

99
Q

Ibuprofen EMS Considerations

A

-Do not administer if the patient has taken maximum dose writhing 6 hours.
-If patient has received less than ten maximum dose of 400mg within 6 hours, administer remaining medication up to the maximum dose of 400mg.
-Works well with pain associated with renal colic, dental, muscoskeletal.
-Cautious use with patients who have past medical history of: recent trauma / suspected subarachnoid hemorrhage, renal impairment, GI bleed, CHF, elderly over 65yrs, chronic alcoholics; can cause bleeding

100
Q

Ipratropium Bromide Trade Name

A

Atrovent

101
Q

Ipratropium Bromide AHS Protocols - Adult

A

Bronchospasm

102
Q

Ipratropium Bromide AHS Protocols - Pediatric

A

Bronchospasm

103
Q

Ipratropium Bromide Classification

A

Anticholinergic Bronchodilator

104
Q

Ipratropium Bromide Mechanism Of Action

A

-Derivative of atropine.
-Exerts anticholinergic action in the bronchioles thereby inhibiting bronchoconstriction.
-Blocks increased mucus secretions.

105
Q

Ipratropium Bromide Indications

A

-Bronchospasm (used with salbutamol)
-Anaphylaxis (used with salbutamol)

106
Q

Ipratropium Bromide Contraindictions

A

-Hypersensitivity
-Hypersensitivity to atropine

107
Q

Ipratropium Bromide Dosage - Adult

A

-MDI with spacer 1 puff (20mcg/puff) q 30-60 seconds prn, max 15 puffs
-500mcg q 5 minutes via nebulizer, max 1500mcg

108
Q

Ipratropium Bromide Dosage - Pediatric; Less than 20kg

A

-1 puff (20mcg/puff) MDI with spacer q 30-60 seconds, max 12 puffs
-250mcg via nebulizer prn, max 750mcg

109
Q

Ipratropium Bromide Dosage - Pediatric; More than / Equal to 20kg

A

-1 puff (20mcg/puff) MDI with spacer q 30-60 seconds, max 15 puffs
-500mcg via nebulizer, max 1500mcg

110
Q

Ipratropium Bromide Side Effects

A

-Dry mouth / throat
-Headache
-Cough
Palpitations
-Tremors
-Dizziness

111
Q

Ipratropium Bromide Pharmacokinetics

A

Onset - 5-15 minutes
Peak - 1-2 hours

112
Q

Ipratropium Bromide EMS Considerations

A

-Invert canister 3 times prior to administration.
-Depress canister to prime prior to administration directed to the floor.
-Direct patient to inhale slowly while administering and hold their breath for 5-10 seconds if possible, repeat 1-2 times to inhale any remaining medication in chamber before removing from mouth.
-MDI needs 30 seconds minimum recharge time between puffs.
-Alternate single puffs with salbutamol during recharge period.
-Nebulizer administration - usually combined with salbutamol to create combivent.
-Nebulizer administration - use non-humidified O2 source at 6-8LPM.
_Enhanced by other anticholinergic drugs.